Study to Assess Impact of Dietary Supplement on Sleep Health
NCT ID: NCT05971771
Last Updated: 2023-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2023-08-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study to Assess a Dietary Supplement on Sleep Health and Quality
NCT05368909
Impact of Nutritional Supplementation on Sleep Quality
NCT06935123
Clinical Study to Investigate the Sleep Quality Enhancing Effect of GABA
NCT04857021
Evaluation of Diphenhydramine Hydrochloride Effects in Subjects With Occasional Sleeplessness
NCT02578186
Benefit of IQP-AO-101 for Sleep
NCT03114696
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active: Sleep Supplement containing Magnesium and Saffron Extract
Powder that is to be mixed into 3oz. of water, 30-60 minutes before going to bed
Treatment
14mg saffron extract and 250mg magnesium citrate that is powder that is mixed in 3-4 oz of water and consumed 30-60 minutes before going to bed
Placebo
Placebo that is 2 softgels that will be taken with water, 30-60 minutes prior to going to bed.
Placebo
Two softgels to be taken with water that is to be consumed approximately 30-60 minutes before going to bed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
Two softgels to be taken with water that is to be consumed approximately 30-60 minutes before going to bed
Treatment
14mg saffron extract and 250mg magnesium citrate that is powder that is mixed in 3-4 oz of water and consumed 30-60 minutes before going to bed
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recorded baseline BMI is ≥18.5 and ≤29.9 kg/m2.
* A score of 5 or higher on the Pittsburgh Sleep Quality Index.
* Willing and able to give informed consent
* Willing to maintain consistent diet and physical activity through the study period.
* Willing to limit alcohol consumption to ≤14 drinks per week, no more than 4 drinks at a time, and no more than 1 drink within 4h of bedtime.
* Willing to limit caffeine consumption to no more than 4 servings per day and no caffeine within 6h of bedtime.
Exclusion Criteria
* Taken nutritional supplements for sleep or stress in the previous 6 months.
* Have received non-pharmacological treatment for sleep disorders (eg. Cognitive behavioral therapy, relation therapy) in previous 6 months
* Any known allergy or intolerance to any of the ingredients contained in supplement.
* Planned surgical procedure during the course of the study.
* Used nicotine in the past 6 months.
* Have a major psychiatric disorder as determined by the Mini International Neuropsychiatric Inventory
* A history of unconventional sleep pattern, a diagnosed sleep disorder, or chronic medical condition that could affect energy/fatigue levels.
* Consume more than 400mg of caffeine per day in the past 2 weeks.
* Used any psychotropic medications, stimulants, cannabis, non-registered drug products, or illicit substances in the past 4 weeks.
* At risk of drug or alcohol abuse
* Used any sleep aids in the past 2 weeks.
* Employed in night shift work or rotational shift work
* Currently pregnant, nursing, planning to become pregnant, or unwilling to use a medically approved form of contraception will be excluded.
* Individuals who sleep more than 10 hours.
* Typically take a nap during the day.
* Those planning travel or vacation during the study period.
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dermatology Consulting Services, High Point NC
OTHER
Pharmanex
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DCS-7-23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.